Enophthalmos and choroidal atrophy after intraophthalmic artery chemotherapy for retinoblastoma

Ophthalmology. 2015 Feb;122(2):435-7. doi: 10.1016/j.ophtha.2014.09.021. Epub 2014 Oct 22.
No abstract available

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Alkylating / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Atrophy
  • Chemotherapy, Cancer, Regional Perfusion / adverse effects*
  • Choroid / pathology
  • Choroid Diseases / chemically induced*
  • Choroid Diseases / diagnosis
  • Combined Modality Therapy
  • Diseases in Twins*
  • Enophthalmos / chemically induced*
  • Enophthalmos / diagnosis
  • Female
  • Fluorescein Angiography
  • Humans
  • Infant
  • Laser Coagulation
  • Magnetic Resonance Imaging
  • Melphalan / administration & dosage
  • Melphalan / adverse effects
  • Ophthalmic Artery
  • Retinal Neoplasms / drug therapy*
  • Retinoblastoma / drug therapy*
  • Scleritis / chemically induced
  • Scleritis / diagnosis
  • Topoisomerase I Inhibitors / administration & dosage
  • Topoisomerase I Inhibitors / adverse effects
  • Topotecan / administration & dosage
  • Topotecan / adverse effects
  • Twins, Monozygotic

Substances

  • Antineoplastic Agents, Alkylating
  • Topoisomerase I Inhibitors
  • Topotecan
  • Melphalan